Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Post Traumatic Stress Disorder
Biotech
Compass, Usona and Transcend score priority vouchers amid psychedelic push
The FDA is awarding national priority vouchers to Compass, Usona and Transcend for their psychedelic treatments.
Will Maddox
Apr 24, 2026 3:51pm
With MDMA debate spreading, Lykos CEO tries to dispel concerns
Jun 13, 2024 10:22am
Lykos' MDMA treatment rejected by FDA committee
Jun 5, 2024 10:20am
Jazz drops PTSD drug over phase 2 trial failure
Dec 22, 2023 5:21am
FDA clears 1st neuromodulation device for PTSD treatment
Mar 24, 2023 10:50am
Study: Sleep wearable could reduce PTSD risk
Aug 17, 2016 10:28am
